<DOC>
	<DOCNO>NCT02396056</DOCNO>
	<brief_summary>Guided bone regeneration ( GBR ) procedures significantly evolve last 20 year . Significant advance make various barrier membrane without use bone graft material . Some main limitation non-resorbable barrier include cytotoxicity need removal , adversely affect regenerate bone volume . Similar GBR success document extensively cell occlusive resorbable barrier membrane . Recently , investigator demonstrate supracrestal bone regeneration guide tissue regeneration procedure human use novel perforate barrier membrane ( MPM ) . The perforation allow mesenchymal stem cell progenitor cell present gingival tissue migrate osseous defect contribute osseous regeneration potential . The objective study investigate GBR potential MPM alveolar ridge defect , relative similar occlusive barrier . Ten non-smoking patient need localize alveolar ridge augmentation prior implant placement include study . Patients divide two group , follow : occlusive bovine collagen membrane ( OM control group , 5 patient ) modify bovine perforate collagen membrane ( MPM test group , 5 patient ) . All site graft mineralized cortical bone allograft need cortical bone pin use site stability . A Cone Bean ( CT ) obtain prior surgery 6-8 month post treatment volumetric width change quantify . A bone biopsy obtain time implant placement ( ~6-8 month ) determine residual graft particles new bone formation . Dimensional width change ass 6-8 month re-entry implant placement . Soft tissue heal assess 2 , 4 , 8 , 16 week 6 month . This study potentially impact current bone augmentation technique may lead modification exist commercial membrane enhance site development prior implant placement . The contribution progenitor cell osseous defect might lead great bone formation possible faster wound healing .</brief_summary>
	<brief_title>Enhancing Guided Bone Regeneration Modifying Resorbable Membrane</brief_title>
	<detailed_description />
	<criteria>augmentation site , alveolar ridge must deficient buccolingual dimension ( &lt; 5.5 mm ) : Class 1 Seibert defect . alveolar ridge augment must minimum 4 mm keratinize gingiva extend length plan augmentation . general contraindication implant surgery subject irradiation , chemotherapy immunosuppressive therapy past 5 year poor oral hygiene motivation uncontrolled diabetes pregnant lactate substance abuser current smoker psychiatric problem unrealistic expectation acute infection area intend implant placement positive HIV hepatitis B C affect autoimmune disease arthritis rheumatoid , systemic lupus erythematosus , sclerodermia , Sjo Ìˆgren syndrome dermatomyositis polymyositis treat treatment intravenous aminobisphosphonates subject previously reconstructive procedure posterior mandible chronic treatment steroid nonsteroidal antiinflammatory drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Guided Bone Regeneration</keyword>
	<keyword>Gingival Mesenchymal Stem Cells</keyword>
</DOC>